Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-35 With Peanut Allergy
Clinical trial NCT04950504 · TERMINATED
Trial details
- NCT number
- NCT04950504
- Sponsor
- COUR Pharmaceutical Development Company, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-02
- Primary completion
- 2022-06-24
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.